News Feed provided by:
Hepatitis Central
Hepatitis C News, Updates and Commentary.
Natalie Cole Optimistic About Her Battle with Hepatitis C
Although currently recovering from combination therapy's side effects, the well-respected vocalist Natalie Cole may have conquered the Hepatitis C virus....
Date: Mon, 21 Jul 2008 10:06:27 -0500
Hep C and Fatty Liver Disease Linked
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease....
Date: Wed, 09 Jul 2008 15:29:15 -0500
Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated...
Date: Wed, 09 Jul 2008 15:23:07 -0500
Popular Illegal Drug Extra Harmful with HCV
Scientists have found a popular street drug worsens Hepatitis C infection in two worrisome ways....
Date: Mon, 07 Jul 2008 12:19:00 -0500
Hep C Long-Term Management Strategies
Since only about half of those on combination therapy beat Hepatitis C, the remaining people must strive to prevent their liver disease from progressing. Thus far, a liver wellness approach is a safer, more effective way to remain healthy compared...
Date: Mon, 07 Jul 2008 12:00:19 -0500
Good News for Non-Responders to HCV Combination Therapy
A Phase 3 trial evaluating ZADAXIN® (thymalfasin) as a potential third component for Hepatitis C traditional combination therapy has just been completed. Although the data is currently being analyzed and won't be available until later in the year, the lead...
Date: Fri, 27 Jun 2008 10:35:43 -0500
Purer, Less Costly Interferon for Hepatitis C and B Treatment
The Taiwan-based biopharmaceutical company PharmaEssentia Corp. is testing P1101, its third-generation PEG-interferon-alpha drug candidate. Because it is a longer-lasting, purer interferon that is less costly to produce, P1101 could enhance the treatment options for Hepatitis C and B....
Date: Mon, 23 Jun 2008 14:35:22 -0500
New Technology May Help Treat Hepatitis
While pharmaceutical companies are racing to find safer, more effective treatments for viral Hepatitis C and B, physicists from Arizona have a unique perspective on accomplishing the same goal. Learn how these scientists believe the virus could be rendered harmless...
Date: Mon, 23 Jun 2008 14:12:48 -0500
Alcoholism and Viral Hepatitis
Conquering viral hepatitis is hard enough without the added challenge of alcoholism. The drug gabapentin as a treatment for alcohol dependence is currently being evaluated in human trials....
Date: Mon, 23 Jun 2008 14:04:30 -0500
HCV Treatment Success: Early Response vs. Genotype
As presented at the April 2008 meeting of the European Association for the Study of the Liver, a rapid virological response can help clinicians customize the length of treatment for Hepatitis C – regardless of genotype....
Date: Wed, 11 Jun 2008 12:26:47 -0500
Fatty Liver Disease is a Major Health Concern
This liver disorder is incredibly common and its progression to a serious disease is usually preventable....
Date: Tue, 10 Jun 2008 14:29:54 -0500
HCV Viral Load Reduced in Phase I/II Trial
Given to those already infected with Hepatitis C, ChronVac-C® is designed to boost the immune response against the virus. Preliminary trial results report a decrease in viral load of over 95 percent in the first patient to complete ChronVac-C® therapy....
Date: Tue, 10 Jun 2008 14:24:08 -0500
New Breakthrough Could Prevent Hepatitis C Replication
Inspired by a pharmaceutical prototype to stop bovine viral diarrhea virus, Immtech reveals that one of their compounds may inhibit Hepatitis C's entry into human cells....
Date: Fri, 06 Jun 2008 17:24:30 -0500
Marijuana Use Sparks Liver Transplant Controversy
Despite its legality in 12 states, learn why medical marijuana use may render a person with Hepatitis C ineligible for a liver transplant....
Date: Mon, 02 Jun 2008 11:28:51 -0500
Optimism Swells After Liver Conference
Several researchers at the May 2008 Digestive Disease Week in San Diego reported encouraging progress in their mission to extinguish liver disease. One of the advancements announced includes monitoring dendritic cells to determine which Hepatitis C patients will fare well...
Date: Fri, 30 May 2008 14:40:49 -0500
Copyright 2008
|
Number Online:
Guests: 6
Members: 1
Total: 7
Online Now: